Speciality Biopharma Building European HQ

Accreate has been retained by a Canadian speciality biopharma company in order to build out their European office, which will be based in Dublin.

This will be a commercial business unit, which will have a focus on launching a soon to be approved, breakthrough therapy for patients with HIV.

As such, we are looking to speak to senior executives with experience in product launches across multiple European markets, knowledge of market access, sales & marketing, pricing & reimbursement or medical & regulatory affairs. It would be a preference that prospective candidates would have speciality pharma and biotech experience.

If looking to enquire, please contact Aisling Fitzpatrick at afitzpatrick@accreate.com or call +353 1 522 5400

David Phelan

David Phelan

Managing Partner
+353 1 5225 413